Skip to main content
OpenTrials
Completed

NCT Number: NCT03859258

Ultrasound Based Study For Niche Development In The Uterine Cesarean Section Scar

The aim of this study is to evaluate different factors affecting niche development in the uterine cesarean section scar in women enrolled 3 to 6 months after cesarean delivery using both TVS and SIS.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Cairo University

Cairo, 113411, Egypt

About this study

Cesarean delivery is amongst the most widely recognized operations performed on women and its rate continue expanding. The rates of cesarean section (CS) in the United States in 1996 and 2009 were 20.7% and 32.3% respectively, witnessing an expansion of more than half. In China, 50% of deliveries in 2010 were through CS. In the Netherlands, the cesarean delivery rate jumped from 7.4 to 15.8% between 1990 and 2008, whereas in the United Kingdom, the CS rate increased from 12 to 29% throughout the same time period. In Brazil, the CS rate jumped from 15% in 1970 to even 80% in 2004.

The expanding rate of cesarean deliveries can be credited to many variables including an increase in repeated cesarean sections. There is no discourse that CS is a lifesaving method for a few women, for instance for women with placenta previa or obstructed labor, or for fetuses with either antenatal or intrapartum distress, breech pregnancy or a twin pregnancy. The World Health Organization suggests that the ideal CS rate should be 15%.

Also, this expanding CS rate has fortified an enthusiasm for the potential long-term morbidity of CS scars. By and large, the cesarean incision heals uneventfully. However, some authors depicted a cesarean scar defect on transvaginal sonography (TVS) or saline infusion sonography (SIS) as a wedge shape anechoic structure at the site of the scar or a gap in anterior myometrium of the anterior lower myometrium at the site of previous cesarean section site. This was first described using hysterosalpingography in 1961. The terminology used to describe these scar abnormalities include scar defects, or 'niches' in the uterine scar, cesarean scar defect, uterine diverticulum, uterine isthmocele, pouch or sacculation and differs various publications. The term 'niche', which was introduced in 2001. A niche appears to be frequently present after a CS. Using SIS, niches were identified in the scar in more than half of the women who had had a caesarean delivery. Niches were defined as indentations of the myometrium of at least 2 mm. Large niches occur less frequently, with an incidence varying from 11 to 45% dependent on the definition used (a depth of at least 50 or 80% of the anterior myometrium, or the remaining myometrial thickness ≤2.2 mm when evaluated by TVS and ≤2.5 mm when evaluated by sonohysterography).

It is usually asymptomatic. Be that as it may, some authors have described some symptoms identified with this condition and there are several studies relating abnormal uterine bleeding and niche, especially postmenstrual spotting which appears to be the most common symptom in women with niches due to the collection of menstrual blood in a uterine scar defect causing postmenstrual spotting.

Later prospective cohort studies reported spotting in ∼30% of women with a niche at 6- 12 months after their CS compared with 15% of women without a niche after CS. It is undoubtedly a generally new pathology that needs assessment.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cases are delivered by Lower segment cesarean section
  • Controls are delivered vaginally
  • Singleton fetus
  • Living fetus
  • Term pregnancy

Exclusion criteria

  • Placenta praevia
  • Congenital fetal anomalies
  • Severe oligohydramnios(MVP <2cm)
  • Rupture of membranes more than 18 hours
  • Puerperal pyrexia or sepsis
  • Bladder injury
  • Blood transfusion

Treatment and study plan

Transvaginal sonography

Device

Niche is assessed using TVS, SIS (cases only) and office hysteroscopy

Other names: SIS, office hysteroscopy

Primary outcomes

  1. Rate of Niche development in the uterine cesarean section scar

    Time frame: baseline

    Measure number of patients that will develop uterine Niche following lower segment cesarean section

Secondary outcomes

  1. Measuring Residual myometrial thickness (RMT)

    Time frame: baseline

    Measuring the remaining myometrium above uterine Niche

  2. Measuring depth of uterine Niche

    Time frame: baseline

    Measuring the depth of cesarean scar defect developed after cesarean section

  3. Measuring width of uterine Niche

    Time frame: baseline

    Measuring the width of cesarean scar defect developed after cesarean section

  4. Assessment of potential risk factors for Niche development

    Time frame: baseline

    Detect why Niche develop

  5. Rate of postmenstrual spotting in patients with uterine Niche

    Time frame: baseline

    Measure number of patients having uterine Niche that will complain from postmenstrual spotting

  6. Rate of uterine Isthmocele development on hysteroscopic evaluation in patients presenting with postmenstrual spotting after cesarean section

    Time frame: basline

    Measure number of patients having uterine Isthmocele detected during hysteroscopic evaluation from all patients presenting with postmenstrual spotting

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

A Prospective Controlled Ultrasound Based Study For Niche Development In The Uterine Cesarean Section Scar With Hysteroscopic Correlation In Symptomatizing Patients

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Mar 1, 2019
Registry last updated
Oct 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.